WallStreetZenWallStreetZen

NYSE: DBD
Diebold Nixdorf Inc Stock

$34.50+0.24 (+0.7%)
Updated Feb 23, 2024
DBD Price
$34.50
Fair Value Price
N/A
Market Cap
$1.30B
52 Week Low
$16.50
52 Week High
$34.81
P/E
N/A
P/B
1.33x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
3.1
Operating Cash Flow
N/A
Beta
0.73
Next Earnings
Apr 22, 2024
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DBD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DBD is good value based on its book value relative to its share price (1.33x), compared to the US Software - Application industry average (6.94x)
P/B vs Industry Valuation
DBD's short-term assets ($2.08B) exceed its short-term liabilities ($1.41B)
Short-term Liabilities Financials
DBD's short-term assets ($2.08B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more DBD due diligence checks available for Premium users.

Be the first to know about important DBD news, forecast changes, insider trades & much more!

DBD News

Valuation

DBD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.33x
Industry
6.94x
DBD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DBD's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%

Assets to liabilities

Assets
$4.0B
Liabilities
$3.0B
Debt to equity
3.1
DBD's short-term assets ($2.08B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DBD's short-term assets ($2.08B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DBD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A

DBD vs App Stocks

TickerMarket Cap1d %P/EP/B
DBD$1.30B+0.70%N/A1.33x
PAR$1.30B-0.22%-19.69x3.90x
PDFS$1.28B-2.39%479.43x5.80x
ETWO$1.27B+0.24%-0.96x0.84x
ADEA$1.22B+2.90%18.03x3.42x

Diebold Nixdorf Stock FAQ

What is Diebold Nixdorf's quote symbol?

(NYSE: DBD) Diebold Nixdorf trades on the NYSE under the ticker symbol DBD. Diebold Nixdorf stock quotes can also be displayed as NYSE: DBD.

If you're new to stock investing, here's how to buy Diebold Nixdorf stock.

What is the 52 week high and low for Diebold Nixdorf (NYSE: DBD)?

(NYSE: DBD) Diebold Nixdorf's 52-week high was $34.81, and its 52-week low was $16.50. It is currently -0.89% from its 52-week high and 109.09% from its 52-week low.

How much is Diebold Nixdorf's stock price per share?

(NYSE: DBD) Diebold Nixdorf stock price per share is $34.50 today (as of Feb 23, 2024).

What is Diebold Nixdorf's Market Cap?

(NYSE: DBD) Diebold Nixdorf's market cap is $1.30B, as of Feb 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Diebold Nixdorf's market cap is calculated by multiplying DBD's current stock price of $34.50 by DBD's total outstanding shares of 37,566,668.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.